Rachel Ward, MD
MOHS-Micrographic Surgery · Muncie, INNPI 1710373378
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,425 of the $9,043 with a category attached, or 82.1%. Mimedx Group, Inc. accounts for 94.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $7,492, more than ten times the $417 reported in 2019.
Across 19 payments — averaging $475.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$9K
- Regeneron Healthcare Solutions, Inc.$125
- AbbVie$122
- Genentech USA, Inc.$80
- Midmark Corporation$55
- Novartis$49
- plus $68 from 3 others
What the payments were for
- Speaking & faculty fees$7,42582%
- Travel & lodging$7779%
- Food & beverage$8419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 8 | $8,545 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| AbbVie | 3 | $122 |
| Genentech USA, Inc. | 1 | $80 |
| Midmark Corporation | 1 | $55 |
| Novartis | 2 | $49 |
| Adaptive Biotechnologies Corporation | 1 | $26 |
| UCB, Inc. | 1 | $23 |
| Acera Surgical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$125
How this compares
Too few mohs-micrographic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 180 | $1,430 |
| Doxycycline Hyclate | 82 | $562 |
| Timolol Maleate | 13 | $380 |
| Cephalexin | 72 | $169 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Muncie
- Carl HankeIndianapolis$96K
- Eduardo RiveraMadison$8K
- John RandallWest Lafayette$6K
- David SurprenantEvansville$5K
- Brian WilliamsGreenwood$5K
- Perry HooperCarmel$5K
- Shayna GordonPlainfield$4K
- Jane LimEvansville$4K
- Thomas McGovernFort Wayne$4K
- Sreya TalasilaPortage$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.